SGLT2 Inhibitors and Perioperative Period

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

October 1, 2025

Conditions

Perioperative Complication

Interventions

DRUG

SGLT2 inhibitor

Dapagliflozin 10 mg or Empagliflozin 25mg

All Listed Sponsors

lead

Assiut University

OTHER

NCT06326528 - SGLT2 Inhibitors and Perioperative Period | Biotech Hunter | Biotech Hunter